Lenapharm SRL
The score of Lenapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +39 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lenapharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 18 Oct 2025
- Year ended 31 Dec 2023filed on 15 Oct 2024
- Year ended 31 Dec 2022filed on 17 Oct 2023
- Year ended 31 Dec 2021filed on 12 Dec 2022
- Year ended 31 Dec 2020filed on 24 Jan 2022
Lenapharm's financial analysis
- Solvency11.2%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lenapharm
Lenapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0556.895.014
- VAT number
- BE0556895014
- Peppol
- Registered · 0208:0556895014 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jul 2014
- Registered office
- 1050 Ixelles
- Latest accounts
- 2024 · filed on 18 Oct 2025
- Activity
- Activities of holding companies (NACE 64210)
Lenapharm (SRL) has been based in Ixelles since 2014, active in: activities of holding companies. For 2024, it reports a net profit of 6,522 € and equity of 119,486 €; its revenue is not published. Its solvency stands at 11.2%, below the median of its sector (60.1%).
Companies similar to Lenapharm
Companies in the same business, of comparable size and area, outside its group.
- Dr. Leen Van de Moortel, Anesthesiste Medical specialists activities Wortegem-Petegem · balance sheet €1.06m
- DR. Dany DE Belder Medical specialists activities Zoersel · balance sheet €1.06m
- Interservus Activities of holding companies Roeselare · balance sheet €1.06m
- Groupe Metal Force Activities of holding companies Genk · balance sheet €1.06m
- Stemda Holding Activities of holding companies Ravels · balance sheet €1.06m
- Acim Finance Rental and operating of own or leased real estate Kortrijk · balance sheet €1.06m
- Chrima - Invest Buying and selling of own real estate Destelbergen · balance sheet €1.06m
- Belfran Raising of other cattle and buffaloes Menen · balance sheet €1.07m
Frequently asked questions about Lenapharm
What is the revenue of Lenapharm?
Lenapharm files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Lenapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0556895014 for Lenapharm, if the company is VAT-registered. Its company number (CBE) is 0556.895.014.
Where is the registered office of Lenapharm?
According to the CBE register, the registered office of Lenapharm is in 1050 Ixelles.
What is the equity of Lenapharm?
At the close of the 2024 financial year, the equity of Lenapharm amounts to 119,486 €, a solvency of 11.2% of total assets.
Who manages Lenapharm?
The register lists 5 active mandates at Lenapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lenapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →